Current Liabilities
Total Current Liabilities
Vertex Pharmaceuticals Total Current Liabilities increased by 0.5% to $3.88B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.6%, from $3.78B to $3.88B. Over 5 years (FY 2020 to FY 2025), Total Current Liabilities shows an upward trend with a 15.5% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryLiquidity
SignalLower is better
VolatilityModerate
First reportedQ4 2014
Last reportedQ1 2026May 5, 2026
How to read this metric
A high or increasing ratio relative to current assets may signal liquidity stress, while a lower ratio suggests better short-term solvency.
Detailed definition
This is the sum of all financial obligations that the company is required to settle within one year. It includes account...
Peer comparison
Standard metric across all sectors; essential for evaluating short-term financial health.
Metric ID:
total_current_liabilitiesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.84B | $1.91B | $2.14B | $2.18B | $2.56B | $2.61B | $2.74B | $3.03B | $3.35B | $3.6B | $3.55B | $3.8B | $3.55B | $3.97B | $3.56B | $3.78B | $4.14B | $4.48B | $3.86B | $3.88B |
| QoQ Change | — | +4.2% | +11.9% | +1.8% | +17.2% | +2.1% | +5.1% | +10.4% | +10.8% | +7.4% | -1.4% | +7.0% | -6.6% | +12.0% | -10.3% | +6.1% | +9.4% | +8.1% | -13.7% | +0.5% |
| YoY Change | — | — | — | — | +39.2% | +36.3% | +28.0% | +38.8% | +31.1% | +37.9% | +29.4% | +25.4% | +5.8% | +10.4% | +0.5% | -0.3% | +16.7% | +12.6% | +8.3% | +2.6% |
Range$1.84B – $4.48B
CAGR+17.1%
Avg YoY Growth+20.2%
Median YoY Growth+21.1%
Total Current Liabilities at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's total current liabilities?
- Vertex Pharmaceuticals (VRTX) reported total current liabilities of $3.88B in Q1 2026.
- How has Vertex Pharmaceuticals's total current liabilities changed year-over-year?
- Vertex Pharmaceuticals's total current liabilities increased by 2.6% year-over-year, from $3.78B to $3.88B.
- What is the long-term trend for Vertex Pharmaceuticals's total current liabilities?
- Over 5 years (2020 to 2025), Vertex Pharmaceuticals's total current liabilities has grown at a 15.5% compound annual growth rate (CAGR), from $1.88B to $3.86B.
- What does total current liabilities mean?
- The total amount of debt and other obligations the company must pay within the next twelve months.